WO2025233682 - ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2025/233682
Publication Date
13.11.2025
International Application No.
PCT/IB2025/000253
International Filing Date
08.05.2025
Title **
[English]
ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS AND USES THEREOF
[French]
CONJUGUÉS ANTICORPS-MÉDICAMENT COMPRENANT DES AGONISTES DE STING ET LEURS UTILISATIONS
Applicants **
LIGACHEM BIOSCIENCES INC.
SONG, Ho Young
KIM, Sung Min
CHAE, Sang Eun
JUNG, Yeong Hun
LEE, Kun Jung
KIM, Ji Soo
PARK, Se Yeon
PARK, Yun-Hee
CHANG, Sook Kyung
PARK, Seongji
BAE, Hyun Joo
CHUNG, Chul-Woong
PARK, Hye Bin
Inventors
SONG, Ho Young
KIM, Sung Min
CHAE, Sang Eun
JUNG, Yeong Hun
LEE, Kun Jung
KIM, Ji Soo
PARK, Se Yeon
PARK, Yun-Hee
CHANG, Sook Kyung
PARK, Seongji
BAE, Hyun Joo
CHUNG, Chul-Woong
PARK, Hye Bin
Priority Data
63/644,292
08.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 13865 | |
| EPO | Filing, Examination, Granting | 293545 | |
| Japan | Filing, Examination, Granting | 5639 | |
| South Korea | Filing, Examination, Granting | 10262 | |
| USA | Filing, Examination, Granting | 54540 |
Total:
377,851
Contact Us
Abstract[English]
The present disclosure relates to a conjugate comprising a STING agonist, linker and antibody or antigen-binding fragment thereof, and uses thereof for the treatment of diseases.[French]
La présente divulgation concerne un conjugué comprenant un agoniste de STING, un agent de liaison et un anticorps ou fragment de liaison à l'antigène de celui-ci, et ses utilisations pour le traitement de maladies.